AgenT

AgenT is a pioneering life sciences startup established in 2018, headquartered in France. The company's mission, encapsulated by its slogan, "Detect Alzheimer's earlier, when it could be prevented," focuses on combating Alzheimer's disease during its silent phase. By leveraging cutting-edge multi-omics assays and advanced machine learning techniques, AgenT has identified novel blood biomarkers that indicate the earliest stages of Alzheimer's, providing a breakthrough in blood diagnostics and precision therapies.

Operating at the intersection of Biotechnology, Health Care, and Life Sciences, AgenT is poised to transform Alzheimer's detection and treatment. Their most recent funding was a €2.30M Seed Round investment secured on 01 July 2021, led by investor Bernard Majoie. This capital injection underscores confidence in their innovative approach, positioning AgenT as a compelling opportunity for investors looking to support advancements in Alzheimer’s treatment and early diagnostics.